Finance

Beta
Lists
FTH:NASDAQ
Faeth Therapeutics, Inc
$36.16
+11.12%
(+3.62) 1D
$36.16
0.00% (0.00)
After hours
Closed: Jul 10, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FTH...
Open
$30.96
High
$36.93
Low
$30.00
Mkt. cap
932.16M
Avg. vol.
65.09K
Volume
238.22K
52-wk high
$36.93
52-wk low
$13.43
EPS
-$142.73
Beta
-0.25
Shares outstanding
25.78M
No. of employees
29
Open
$30.96
High
$36.93
Low
$30.00
Mkt. cap
932.16M
Avg. vol.
65.09K
Volume
238.22K
52-wk high
$36.93
52-wk low
$13.43
EPS
-$142.73
Beta
-0.25
Shares outstanding
25.78M
No. of employees
29
News stories
From sources across the web
About Faeth Therapeutics, Inc
CEO-
Employees29
Founded1999
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitefaeththerapeutics.com
Analyst ratings
Based on 6 analysts giving stock ratings to FTH in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for FTH in the last 3 months.
Highest
Current $36.16
$60.00 (+65.93%)
Average
$55.40 (+53.21%)
Lowest
$50.00 (+38.27%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeet Mukherjee
BTIG
Buy
Maintained
$55.00
+52.1%
07/01/2026
Jack Allen
Robert W. Baird
Buy
Initiated
$57.00
+57.6%
06/26/2026
Patrick Trucchio
H.C. Wainwright
Buy
Initiated
$60.00
+65.9%
06/23/2026
Geoff Meacham
Citi
Buy
Maintained
$55.00
+52.1%
06/11/2026
Li Watsek
Cantor Fitzgerald
Buy
Maintained
-
-
06/03/2026
Christopher Liu
Lucid Capital
Buy
Initiated
$50.00
+38.3%
05/28/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.53M
2.54M
2.17M
150.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.67M
2.32M
2.79M
19.71M
Operating expense
5.21M
4.85M
4.96M
170.63M
Total operating expenses
5.21M
4.85M
4.96M
170.63M
Operating income
-5.21M
-4.85M
-4.96M
-170.63M
Other non operating income
-1.00K
-
-115.00K
-104.00K
EBT including unusual items
-4.94M
-4.57M
-4.72M
-170.24M
EBT excluding unusual items
-4.90M
-4.57M
-4.85M
-170.34M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.94M
-4.57M
-4.72M
-170.24M
Net profit margin
-
-
-
-
Earnings per share
-3.91
-
-
-
Interest and investment income
321.00K
289.00K
223.00K
392.00K
Interest expense
-10.00K
-6.00K
-3.00K
-
Net interest expenses
311.00K
283.00K
220.00K
392.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.17M
-4.82M
-4.92M
-170.60M
Gain or loss from assets sale
40.00K
1.00K
-21.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer